tm logo
EMD SERONO
SEARCHED

on 19 Aug 2024

Last Applicant/ Owned by

MERCK KGAA

Frankfurter Str. 25064293 Darmstadt,

DE

Serial Number

2220963 filed on 09th Nov 2022

Correspondent Address

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOTTAWA

ONTARIO

CA

K1P5Y6

EMD SERONO

Trademark usage description

pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for use in gastroenterology; pharm Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of genetic diseases and disorders, namely endocrine, neurological, namely, Alzheimer's, Huntington's Disease and cerebral palsy, oncological and infertility; pharmaceutical hormonal preparations, namely endocrine; pharmaceutical preparations for the treatment of immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes; anti-inflammatory preparations; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of musculo-skeletal diseases and disorders, namely, multiple sclerosis treatment, rheumatoid arthritis and auto-immune diseases; pharmaceutical preparations for the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Parkinson's disease, multiple sclerosis; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of psychiatric and other brain diseases and disorders, namely, anxiety, mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, multiple sclerosis; pharmaceutical preparations for reproductive health diseases and disorders, namely pharmaceutical hormonal preparations, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of pulmonary hypertension; pharmaceutical preparations for the treatment of pulmonary diseases and disorders, namely, lung cancer; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of rheumatological diseases and disorders, namely, rheumatoid arthritis and auto-immune diseases; pharmaceutical preparations for the treatment of viral diseases, namely Immuno-oncology; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; pharmaceutical preparations for human use, namely preparations for the treatment of infertility diseases and disorders


Classification kind code

11

Class [009]
Mobile medical apps and web applications (software) to support patients with chronic diseases and disorders; computer programs to be used to administer and transfer medical and patient data in the therapeutic area of endocrinology and neurology and fertility; computer software for identifying, providing and tracking information related to growth hormone deficiency, Turner's syndrome and diseases and disorders in the field of fertility; downloadable software, namely a comprehensive and customizable database offering information regarding the clinical use of medications and natural remedies; downloadable software, namely a medical reference databases for use by healthcare providers and patients; computer software for use in treating and diagnosing neurological, immunological, endocrine, fertility and inflammatory diseases and disorders; downloadable periodical publications; electronic medical publications


Classification kind code

11

Class [010]
Medical apparatus and instruments, namely, injection syringes, pre-filled injectors, pen-injectors, auto-injectors and needles for administering pharmaceuticals


Classification kind code

11

Class [041]
Educational services, namely, conducting seminars, conferences, workshops in the fields of oncology, fertility, growth hormone therapy, neurology; education, namely, teaching and training in the field of medicine and health; educational services, providing of training and education, namely, providing information to caregivers in the area of healthcare, diseases management, patient support services, namely, providing caregivers with medical information about the range of possible diagnoses and therapies in the field of medicine, pharmaceuticals and clinical trials


Classification kind code

11

Class [042]
Medical research, clinical medical research, scientific research in the field of pharmaceuticals; scientific and technological services, namely, scientific research, industrial research, analysis, testing in the field of endovascular, cardiovascular, neurological, fertility, immunological, inflammatory, oncological, endocrine and viral procedures


Classification kind code

11

Class [044]
Medical services, namely, providing medical information, medical counseling, medical laboratory services, medical research services; medical clinic services; providing medical assistance, namely, providing information to health care professionals in the area of healthcare, disease management, patient support services


Classification kind code

11

Mark Details


Serial Number

2220963

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 22
on 19th Aug 2024
Search Recorded
Submitted for opposition 20
on 19th Aug 2024
Examiner's First Report
Submitted for opposition 287
on 17th Nov 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 09th Nov 2022
Filed
Submitted for opposition 1
on 09th Nov 2022
Created
Submitted for opposition 31
on 09th Nov 2022
Formalized